Key Financial Ratios


Change Company Name
 
Lyka Labs Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500259
NSE Symbol
LYKALABS
P/E
0
ISIN Demat
INE933A01014
Div & Yield %
0
EPS
0
Book Value
37.02
Market Cap (Rs Cr.)
183.02
Face Value
10
ParticularsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.410.731.645.7712.15
Long Term Debt-Equity Ratio0.260.601.024.2011.23
Current Ratio1.301.250.680.620.84
Fixed Assets0.790.690.500.980.41
Inventory12.2312.9010.6626.3412.44
Debtors4.074.964.6411.967.55
Interest Cover Ratio5.990.810.484.020.28
PBIDTM (%)15.0215.1823.6458.1424.41
PBITM (%)10.233.636.8648.7711.48
PBDTM (%)13.3110.679.2846.02-16.62
CPM (%)10.909.429.0533.64-10.30
APATM (%)6.11-2.13-7.7324.28-23.23
ROCE (%)6.370.000.0035.980.00
RONW (%)4.990.000.0058.270.00